Stem Cells for Skeletal Muscle Tissue Engineering
Volumetric muscle loss (VML) is a debilitating condition wherein muscle loss overwhelms the bodys normal physiological repair mechanism. VML is particularly common among military service members who have sustained war injuries
Volumetric muscle loss (VML) is a debilitating condition wherein muscle loss overwhelms the body"s normal physiological repair mechanism. VML is particularly common among military service members who have sustained war injuries. Because of the high social and medical cost associated with VML and suboptimal current surgical treatments, there is great interest in developing better VML therapies. Skeletal muscle tissue engineering (SMTE) is a promising alternative to traditional VML surgical treatments that use autogenic tissue grafts, and rather uses isolated stem cells with myogenic potential to generate de novo skeletal muscle tissues to treat VML. Satellite cells are the native precursors to skeletal muscle tissue, and are thus the most commonly studied starting source for SMTE. However, satellite cells are difficult to isolate and purify, and it is presently unknown whether they would be a practical source in clinical SMTE applications.
Alternative myogenic stem cells, including adipose-derived stem cells (ADSCs), bone marrow-derived mesenchymal stem cells (BM-MSCs), perivascular stem cells (PVSCs), umbilical cord mesenchymal stem cells (UC-MSCs), induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) each have myogenic potential and have been identified as possible starting sources for SMTE, though they have yet to be studied in detail for this purpose.
These alternative stem cell varieties offer unique advantages and disadvantages that are worth exploring further to advance the SMTE field towards highly functional, safe, and practical VML treatments. The following review summarizes the current state of satellite cell-based SMTE, details the properties and practical advantages of alternative myogenic stem cells, and offers guidance to tissue engineers on how alternative myogenic stem cells can be incorporated into SMTE research.
Research:https://www.liebertpub.com/doi/full/10.1089/ten.teb.2017.0451
ارسال به دوستان